This article is more than 5 years old. Information may no longer be current.

OPKO Health completes acquisition of Ophthalmic Technologies

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

MIAMI — OPKO Health has completed its previously announced acquisition of Ophthalmic Technologies, according to a press release from the company.

Ophthalmic Technologies (OTI) is a privately owned Canadian company that provides ophthalmic diagnostic and imaging equipment for both routine and specialized situations. The company recently introduced the Spectral SLO OCT system, the release said.

"OPKO has already made excellent progress in integrating OTI, as we have actively worked together over the past months to prepare for the recent market introduction of our breakthrough Spectral SLO OCT system," said Rishard Weitz, OTI president, in the release.

"Our team believes there is the potential for powerful synergies between OPKO's therapeutics pipeline and the diagnostic systems and devices used by eye care professionals, and we expect OTI to continue to play an important strategic role in OPKO's plans for a broadly based ophthalmic business," he said.